EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Coreana Cosmetics Co.Ltd (027050) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Coreana Cosmetics Co.Ltd KRW 586, price KRW 1,279, upside -54.2%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · KR · ISIN KR7027050004

CC Thin data Oct 3, 2026

Coreana Cosmetics Co.Ltd

027050 · KQ

Weakest SetupStrongly overvalued and low quality.

Low debt
Quality 41/100
Fair value 586.41 KRW · Strongly overvalued (−54.2%)
Weak Growth (revenue 5y −3.2 %/yr in KRW)
Loss-making · -12.5% net margin (TTM)
Negative free cash flow
Trails peers (1/8)
Narrow moat 8/100
Thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

5,240 KRW 1,193 KRW Fair Value 586.41 KRW May 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range 1,193 KRW – 5,240 KRW · fair‑value band 387.03 KRW – 733.01 KRW · the 1,279 KRW price screens above the 586.41 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.

Follow Coreana Cosmetics Co.Ltd in your weekly email

Every Wednesday you see whether Coreana Cosmetics Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Coreana Cosmetics Co.,Ltd. engages in the manufacture and sale of cosmetics in South Korea and internationally. The company offers its products under the LAVIDA, Ample:N, RODIN, Preange, Orthia, SENITE, GAON, Korean Therapy Gayeonhwa, Cellenique, InsLab, Artscien, Aganoori, and Seduire brand names.

Show more

Coreana Cosmetics Co.,Ltd. engages in the manufacture and sale of cosmetics in South Korea and internationally. The company offers its products under the LAVIDA, Ample:N, RODIN, Preange, Orthia, SENITE, GAON, Korean Therapy Gayeonhwa, Cellenique, InsLab, Artscien, Aganoori, and Seduire brand names. It is also involved in the operation of skin care shop; and real estate rental activities. The company was founded in 1988 and is based in Cheonan-si, South Korea.

Stock analysis

Coreana Cosmetics Co.Ltd (027050) currently trades at 1,279 KRW, while our model-based Fair Value estimate is 586.41 KRW, 54.2% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 387.03 KRW (bear) to 733.01 KRW (bull), the price of 1,279 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Coreana Cosmetics Co.Ltd reported revenue of 73.7B KRW in FY2025 versus 87.1B KRW in FY2021, a compound −4.1%/yr. Reported net income was −7.7B KRW in FY2025.

Key figures

Market cap 41.2B KRW (≈ $30.6M) · P/S ratio 0.57 · Net margin −10.5% · Return on equity −10.6% · Return on assets (EBIT) 0.1% · Operating margin −5.6% · Revenue (TTM) 71.7B KRW · Revenue growth (YoY) −7.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).

What moves the price

The share trades about 54% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −29% fair-value upside, at −54%, 027050 screens richer than that median.

Fair Value models

Bear 387.03 KRW Fair Value 586.41 KRW Bull 733.01 KRW
Price 1,279 KRW · Upside -54.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 1,300 KRW 1,742 KRW 2,600 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 1,300 KRW 1,742 KRW 2,600 KRW 54

Open the full fair value analysis →

Notify me when 027050 reaches fair value

Put 027050 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 41/100

Of which business quality 41 · Market factors (momentum, volatility) 28

Profitability 20
Margins and returns on capital today
Quality Growth 15
Are margins and returns improving?
Cashflow 6
Earnings quality: real cash, not paper profit
Fin. Strength 80
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 64
Calm price path (market factor)
Momentum 20
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 44
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−10.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.2%
Start year 2020 (pandemic). Over 10 years: −6.0% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.9% (2020) → −5.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

027050 screens overvalued: fair value 54% below the price. Compare with Colgate-Palmolive Company →

Compare Coreana Cosmetics Co.Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 242 stocks

Beats the industry median on 0/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside −54.2% · Bottom 25%
Profitability
Return on assets −2.7% · Bottom 25%
Net margin (TTM) −12.5% · Bottom 25%
Operating margin (TTM) −5.6% · Bottom 25%
Growth and dividend
Revenue growth −7.7% · Bottom 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 31
FUTURE (revenue growth)0 · sector 19
PAST (return on equity)0 · sector 29
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 54

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Colgate-Palmolive Company CL $84.26 $56.16 −33%
Hindustan Unilever Limited HINDUNILVR ₹1,836 ₹775.25 −58%
Kenvue Inc KVUE $17.80 $12.72 −29%
The Estée Lauder Companies Inc EL $90.19 $44.21 −51%
Kimberly-Clark Corporation KMB $94.36 $83.77 −11%
Henkel AG HEN €66.35 €82.61 +25%
Church & Dwight Co CHD $94.31 $65.04 −31%
Beiersdorf Aktiengesellschaft, BEI €75.40 €69.09 −8%
Puig Brands, S.A PUIG €17.84 €24.28 +36%
Marico Limited MARICO ₹781.35 ₹493.84 −37%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Coreana Cosmetics Co.Ltd Fair Value". https://www.fairvalue-calculator.com/stock/027050

Frequently asked questions

Is Coreana Cosmetics Co.Ltd (027050) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 586.41 KRW versus a price of 1,279 KRW, about −54% upside (overvalued).
What is the fair value of 027050?
Our model-based fair value for Coreana Cosmetics Co.Ltd is 586.41 KRW (as of Oct 3, 2026), built from audited fundamentals. The current price: 1,279 KRW.
What is the quality score of 027050?
Coreana Cosmetics Co.Ltd has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Coreana Cosmetics Co.Ltd (027050)?
Our model-based price target is the fair value of 586.41 KRW (as of Oct 3, 2026) from 1 valuation models. Cautious scenario 387.03 KRW, optimistic scenario 733.01 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Coreana Cosmetics Co.Ltd stock forecast for 2026?
Our models put fair value at 586.41 KRW, about −54% upside versus a price of 1,279 KRW (overvalued). Cautious scenario 387.03 KRW, optimistic scenario 733.01 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Coreana Cosmetics Co.Ltd (027050)?
Coreana Cosmetics Co.Ltd reported trailing-twelve-month revenue of about 71.7B KRW (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Coreana Cosmetics Co.Ltd (027050)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Coreana Cosmetics Co.Ltd it is 586.41 KRW per share (as of Oct 3, 2026), against a price of 1,279 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Coreana Cosmetics Co.Ltd stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 027050 trades above its calculated fair value: price 1,279 KRW, fair value 586.41 KRW, a gap of about −54% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 027050?
No. The price is what the market pays today (1,279 KRW); the fair value is what the company's own numbers justify (586.41 KRW). For Coreana Cosmetics Co.Ltd the two are 692.59 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Coreana Cosmetics Co.Ltd worth?
The market values Coreana Cosmetics Co.Ltd at about 41.2B KRW (market capitalisation, as of Oct 3, 2026). Per share that is 1,279 KRW; our models calculate a fair value of 586.41 KRW per share.
What do the bullish and bearish scenarios say about 027050?
Our models span a range for Coreana Cosmetics Co.Ltd: cautious scenario 387.03 KRW, base 586.41 KRW, optimistic 733.01 KRW per share (as of Oct 3, 2026, price 1,279 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Coreana Cosmetics Co.Ltd (027050)?
Balance-sheet figures for Coreana Cosmetics Co.Ltd (as of Oct 3, 2026): return on equity −10.6%. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is 027050 from its 52-week high?
Coreana Cosmetics Co.Ltd trades at 1,279 KRW, about 54% below its 52-week high of 2,800 KRW and 7% above the low of 1,193 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 586.41 KRW is for.
Which stocks are comparable to Coreana Cosmetics Co.Ltd?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Coreana Cosmetics Co.Ltd stock attractive at the current price?
The data as of Oct 3, 2026: price 1,279 KRW, calculated fair value 586.41 KRW (−54%), Quality Score 41/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 027050 calculated?
We run Coreana Cosmetics Co.Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 586.41 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Coreana Cosmetics Co.Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Coreana Cosmetics Co.Ltd (027050)?
The closing price on Oct 2, 2026 was 1,279 KRW. Our model-based fair value is 586.41 KRW, about −54% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Coreana Cosmetics Co.Ltd right now?
The price sits above even our optimistic bull case (733.01 KRW). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (387.03 KRW to 733.01 KRW) leaves room in how you read the outcome.

Key figures of Coreana Cosmetics Co.Ltd

How large is the market capitalisation of Coreana Cosmetics Co.Ltd (027050)?
The market capitalisation of Coreana Cosmetics Co.Ltd is 41.2B KRW (≈ $30.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Coreana Cosmetics Co.Ltd (027050)?
The price-to-sales ratio of Coreana Cosmetics Co.Ltd is 0.57 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Coreana Cosmetics Co.Ltd (027050)?
The net margin of Coreana Cosmetics Co.Ltd is −10.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Coreana Cosmetics Co.Ltd (027050)?
The return on equity (ROE) of Coreana Cosmetics Co.Ltd is −10.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Coreana Cosmetics Co.Ltd (027050)?
On an EBIT basis the return on assets of Coreana Cosmetics Co.Ltd is 0.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Coreana Cosmetics Co.Ltd (027050)?
The operating margin of Coreana Cosmetics Co.Ltd is −5.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Coreana Cosmetics Co.Ltd (027050)?
Revenue at Coreana Cosmetics Co.Ltd is growing −7.7% versus a year earlier (3y avg −2.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Coreana Cosmetics Co.Ltd (027050)?
Earnings per share at Coreana Cosmetics Co.Ltd are growing +127% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Coreana Cosmetics Co.Ltd (027050) generate?
The free cash flow of Coreana Cosmetics Co.Ltd is −1.8B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Coreana Cosmetics Co.Ltd (027050) carry?
The net debt of Coreana Cosmetics Co.Ltd is 2.0B KRW (fiscal year 2020). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Coreana Cosmetics Co.Ltd in the live analysis

One click puts Coreana Cosmetics Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.